Natures Sunshine Products EV/EBIT NATR

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026: 5.2×
10-year median: 12.1×
Against its 10-year history: 1st; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.7× to 63.5×
Peer median: 3.5×

Natures Sunshine Products' EV/EBIT is 5.2× as of Oct 23, 2026.

That is below its ten-year median of 12.1×, lower than on 99% of days in the last ten years.

Over that time it ranged from 4.7× in Apr 2020 to 63.5× in May 2018.

The median for 10 large drugmakers of a similar size is 3.5×.

EV/EBIT over time

median 12.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	5.2×	5.2×	17.1×
2025	12.6×	7.3×	13.5×
2024	10.4×	8.5×	17.0×
2023	16.0×	6.4×	18.0×
2022	6.3×	5.1×	10.9×
2021	10.8×	9.7×	15.8×
2020	10.4×	4.7×	12.9×
2019	10.5×	10.5×	19.9×
2018	15.7×	14.1×	63.5×
2017	44.8×	12.4×	49.9×
2016	21.9×	6.6×	26.5×
2015	9.9×	6.9×	12.6×
2014	8.9×	6.3×	9.7×
2013	8.1×	4.3×	9.1×
2012	4.1×	4.1×	9.6×

Against its peers

Companies in Drug Manufacturers - General nearest Natures Sunshine Products' size, closest first, today.

Company	EV/EBIT
NATRNatures Sunshine Products	5.2×
ARVNArvinas	n/m
PBYIPuma Biotechnology	15.6×
IRWDIronwood Pharmaceuticals	3.5×
ZVRAZevra Therapeutics	2.9×
CRMDCorMedix	2.3×
LFVNLifevantage	9.6×
SPROSpero Therapeutics	2.1×
COLLCollegium Pharmaceutical	9.4×
ABUSArbutus Biopharma	4.9×
ATNMActinium Pharmaceuticals	1.2×
Peer median	3.5×

Where Natures Sunshine Products ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Natures Sunshine Products

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.